Why Drug Price Negotiation Has Staying Power June 25, 2021 Perspective In this Axios column, Drew Altman looks beyond Medicare to what’s at stake for employers and workers in the debate about the government negotiating drug prices.
The Health System Appears To Be Selling LGBT+ People Short August 2, 2021 Perspective With much focus on equity in the nation’s health care system during the pandemic, Drew Altman’s Axios column brings attention to warning signs about health care provided to LGBT+ individuals.
Corporate Leaders Are Getting Bullish On Government Action On Health Care Costs April 29, 2021 Perspective In this Axios column, Drew Altman explores whether the long struggle with rising health costs has caused the tide to turn in corporate leaders’ attitudes towards government involvement in controlling health spending and whether it is part of a larger shift in comfort with government action to solve problems.